News
OPRX
--
0.00%
--
3 Monster Growth Stocks That Are Ready to Run Higher
What can you make of the market’s standard disclaimer, ‘past performance cannot guarantee future returns.' Should you avoid every stock that has shown enormous growth in recent months? Or should you ignore it, and focus on the fast-appreciating equities? T...
TipRanks · 1d ago
8-K: OptimizeRx Corp
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 4d ago
OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at H.C. Wainwright's BioConnect Conference being held virtually on January 11-14, 2021.
GlobeNewswire · 01/06 12:31
OptimizeRxs TelaRep Recognized as One of the Most Innovative Products for Life Sciences by PM360
TelaRep Helps Replace Lost In-Person Interactions Between Life Sciences and ProvidersROCHESTER, Mich., Dec. 11, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians ...
GlobeNewswire · 12/11/2020 12:31
OptimizeRx's TelaRep(TM) Recognized as One of the Most Innovative Products for Life Sciences by PM360
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced its virtual communication solution, TelaRep , has been recognized as one of the most innovative products for life...
GlobeNewswire · 12/11/2020 12:31
How Many OptimizeRx Corporation (NASDAQ:OPRX) Shares Did Insiders Buy, In The Last Year?
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Simply Wall St. · 12/11/2020 08:02
OptimizeRx CEO, William Febbo, To Speak At Bank Of America 4th Annual HCIT And Digital Health Symposium Today, December 9, 2020
ROCHESTER, Mich., Dec. 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ:OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to
Benzinga · 12/09/2020 12:32
OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 2020
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to participate at the Bank of America 4 Annual HCIT and Digital Health Symposium on December 9-10.
GlobeNewswire · 12/09/2020 12:31
OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 2020
ROCHESTER, Mich., Dec. 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to participate at the Bank of America 4th Annual HCIT ...
GlobeNewswire · 12/09/2020 12:31
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
OptimizeRx Corp. (NASDAQ:OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has partnered with Komodo Health, a data-driven healthcare software company with access
Benzinga · 12/07/2020 12:32
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has partnered with Komodo Health, a data-driven healthcare software company with access to the broadest array of real-world...
GlobeNewswire · 12/07/2020 12:31
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
Komodo’s Extensive Healthcare Map Powers Precise Care Milestone Mapping, Improving Support for Providers and PatientsROCHESTER, Mich., Dec. 07, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for lif...
GlobeNewswire · 12/07/2020 12:31
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has introduced a transformative enhancement to its digital health and communications platform.
GlobeNewswire · 12/01/2020 17:20
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
GlobeNewswire · 12/01/2020 12:31
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
GlobeNewswire · 12/01/2020 12:31
Do Hedge Funds Love OptimizeRx Corporation (OPRX)?
Insider Monkey · 11/29/2020 14:33
Do Hedge Funds Love OptimizeRx Corporation (OPRX)?
Insider Monkey · 11/29/2020 14:33
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloittes 2020 Technology Fast 500
GlobeNewswire · 11/18/2020 12:31
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500(TM)
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, has ranked 432 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. OptimizeRx grew revenue 217% from 2016 to 2019.
GlobeNewswire · 11/18/2020 12:31
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloittes 2020 Technology Fast 500
Attributes 217% Revenue Growth to Rapidly Expanding Digital Health PlatformROCHESTER, Mich., Nov. 18, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, has ranked 432 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. OptimizeRx grew revenue 217% from 2016 to 2019. OptimizeRx CEO William Febbo credits the company’s innovative digital health solutions, expanding client base and dedicated team with the company’s 217% revenue growth. He stated: "It is an honor to be recognized by Deloitte as one of the nation’s fastest growing companies. Our team has worked tirelessly and vigorously to get the company to where it is today. The company’s strong growth is a testament to our mission in providing quality, affordable healthcare solutions to both patients and physicians, especially in this post COVID world. We are positioned very well to capitalize on our near-term growth opportunities as we continue to provide long-term value for our shareholders.”Paul Silverglate, vice chairman, Deloitte LLP and U.S. technology sector leader, commented: “For more than 25 years, we’ve been honoring companies that define the cutting edge and this year’s Technology Fast 500 list is proof positive that technology — from software and digital media platforms, to biotech — truly does permeate so many facets of our lives. We congratulate this year’s winners, especially during a time when innovation is needed more than ever to address the monumental challenges posed by the pandemic.”“Each year the Technology Fast 500 listing validates how important technology innovation is to our daily lives. It was interesting to see this year that while software companies continued to dominate, biotech companies rose to the top of the winners list for the first time, demonstrating that new categories of innovation are accelerating in the pursuit of making life easier, safer and more productive,” said Mohana Dissanayake, partner, Deloitte & Touche LLP, and industry leader for technology, media and telecommunications, within Deloitte’s audit and assurance practice. “We extend sincere congratulations to these well-deserved winners — who all embody a spirit of curiosity, and a never-ending commitment to making technology advancements possible.”OptimizeRx recently reported that its revenue for the third quarter of 2020 increased 110% to a record $10.5 million versus the same year-ago quarter. The result keeps the company on track for another year of record growth in an expanding addressable market. About Deloitte’s 2020 Technology Fast 500™ Now in its 26th year, Deloitte’s Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $US50,000, and current-year operating revenues of at least $US5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.About Deloitte Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.About OptimizeRx OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care, to retail pharmacy, through mobile patient engagement.For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com. OptimizeRx Contact  Doug Baker, CFO Tel (248) 651-6568 (x807) dbaker@optimizerx.com Media Contact Maira Alejandra, Media Relations Manager Tel (754) 245-7070 malejandra@optimizerx.comInvestor Relations Contact  Ron Both, CMA  Tel (949) 432-7557  oprx@cma.team
GlobeNewswire · 11/18/2020 12:31
Webull provides a variety of real-time OPRX stock news. You can receive the latest news about OPTIMIZERX through multiple platforms. This information may help you make smarter investment decisions.
About OPRX
OptimizeRx Corporation is a digital health company that facilitates communication at point-of-care among stakeholders in healthcare. The Company provides electronic clinical information through electronic health records (EHRs) to the medical profession, providing a direct channel for pharmaceutical companies to communicate with healthcare providers. Primarily focused on life science and payer clients, its suite of digital and mobile software as a service (SaaS)-based solutions enables affordability, patient adherence and care management. The Company’s products and applications include financial messaging, brand and clinical messaging, brand support, patient engagement and digital therapeutics. Its integrated financial messaging platform is a virtual patient support center that allows doctors and staff to access a universe of sample vouchers, co-pay coupons and other patient support through their electronic medical record (EMR) and/or e-Prescribe systems.
More